IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
IM Cannabis Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026
$1.50+0.11 (+7.91%)
Close on Oct 19, 2026
IM Cannabis Corp. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Cannabis Products [Member] | C$53.19M | C$51.34M | C$44.25M | C$48.38M | – | – | – | 97.2% | +3.6% |
| Other products [Member] | C$1.55M | C$2.70M | C$4.56M | C$5.95M | – | – | – | 2.8% | -42.7% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Germany [Member] | C$36.35M | C$15.51M | C$5.49M | C$3.84M | C$8.62M | C$2.06M | C$654.00K | 66.4% | +134.4% |
| Israel [Member] | C$18.38M | C$38.52M | C$43.32M | C$50.50M | C$25.43M | C$13.83M | C$8.42M | 33.6% | -52.3% |
| Adjustments [Member] | C$0 | C$0 | C$0 | C$0 | C$0 | C$0 | – | 0.0% | – |
| Canada [Member] | – | – | – | – | C$20.25M | C$0 | – | – | – |
| Israel | – | – | C$43.32M | C$50.50M | C$25.43M | – | – | – | – |
From the segment and revenue-disaggregation notes of IM Cannabis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.